Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. - Wikidata - thesis-toulmin - TriplyDB

Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

http://www.wikidata.org/entity/Q34405506

about

Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness Epigenetics of inflammation, maternal infection, and nutrition Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells Targeting CSC-related miRNAs for cancer therapy by natural agents Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules MicroRNAs targeting prostate cancer stem cells The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells A miRNA signature for defining aggressive phenotype and prognosis in gliomas.VEGF receptors mediate hypoxic remodeling of adult ovine carotid arteries.Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers The role of epithelial plasticity in prostate cancer dissemination and treatment resistance The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.Association between HIF1A P582S and A588T polymorphisms and the risk of urinary cancers: a meta-analysis Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells.Effects of oxygen on the antigenic landscape of prostate cancer cells.Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.Cancer stem cells and chemoresistance: The smartest survives the raid Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.New perspectives of curcumin in cancer prevention.Cancer prevention and therapy through the modulation of the tumor microenvironment.Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.MicroRNAs and epithelial-mesenchymal transition in prostate cancer.miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma.MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.The bounty of nature for changing the cancer landscape.FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma.Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.MicroRNA-210 and its theranostic potential.Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?

P2860

Q24301752-BE58FBE4-04FC-4EF8-B574-A05E20180AA5 Q26747518-1C0C97C7-D871-453A-9E11-4B65B7E8D35E Q26822776-EAD73225-6A11-4FD4-B4A4-E16A700ECA67 Q26828350-1E6EF254-5F4C-4E38-B30B-2A868E6DAD8B Q26853528-1FA5BC39-BDE1-4564-BE61-40F9CF71D333 Q27003230-A06767EA-A97E-4B03-8AA7-AB6AC8A635DE Q27333594-7CC23E54-739B-4542-9AFA-0C5C9F52442C Q28081039-F340CA3A-58B7-42FD-84BB-19348EFF94ED Q28085385-BF10E34B-8268-4F4A-87EA-0FF893C35171 Q28534382-5528FBA2-CF39-45E8-9E2F-E66C46FDF524 Q33648460-5C9DB4B8-5F63-4388-8B28-17D38F59A9FD Q34287223-450F4B5A-62CF-406B-92FA-E46EF436D25E Q34295320-C401F61E-19E0-4339-B53C-00634AC910E2 Q34357952-858FB1F6-AC1A-4B4E-848B-9F568F3ADDB4 Q34505037-7D9B4D4C-53BD-4978-B3E6-BFD0BB98DB8C Q34690409-54D7E30A-872A-4F4E-A077-03AF103E2CD2 Q34749270-442C2846-A9C1-48BD-BCE7-FA7FD8945FF5 Q35666501-02E4ADEB-1268-4E7C-88C8-F7A95E5D6F7C Q35845496-09826562-9487-4BF9-ABE9-A0C57AD860EC Q36688942-715A030B-D195-4F7B-AC74-A1F501AFA1AD Q36689042-682F21C4-B8CE-4774-BF94-C927DFFFC118 Q36730432-F69185F4-F388-489F-B2F2-77C9FE6B6340 Q36772115-BBD6C34C-A764-49DA-AE6C-010459AC65A3 Q36957733-8831CAAC-D65E-49D4-BE16-675739CE083F Q37058267-46449057-C228-4FBF-B712-983E8C688029 Q37319292-0657C963-7ED9-490D-AF98-6FD9C0014275 Q37610799-F489DAC4-6D2F-42EC-883F-2099B6165D38 Q37687205-1E806DCC-1E06-4EAA-B328-4E18AC4BCF80 Q37707562-D8E63D4B-6D9F-48F0-9E50-885CC2895636 Q38086010-C015578D-B09C-4206-A861-2317B5280707 Q38095501-99D94B98-E376-4F2E-A2E9-D34A5238442D Q38667234-C241EBCA-AD22-4943-92BA-4BC79A10627A Q38707912-93E06573-97AE-405C-90E7-4D5C29FD27D2 Q38751296-8CA0BB19-DB91-4A73-B1A6-AA03DD7691F1 Q38779835-7F9F6B0E-614B-4B61-A1ED-A309D8A9A995 Q38816103-1C91AD8C-B2A3-40CB-B337-1DF598FF4557 Q38881607-1D577FA1-43D2-49DC-97F0-3CA363A01AC2 Q38885853-B2F3E7CB-748C-47A3-9719-FA3092B0C637 Q39124675-CF552F36-DE8F-41E2-9DFC-6583AABB24B7 Q39340502-8BC05024-3C88-4C5F-9358-F246A6A433B4

P2860

Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

http://www.wikidata.org/entity/Q34405506

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@ast

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@en

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@nl

type

label

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@ast

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@en

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@nl

prefLabel

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@ast

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@en

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@nl

P1433

Q34405506-0565B405-0FED-43B0-900B-913775F2E45B

P1476

Q34405506-806BDD0B-F283-4DD2-8F00-879F563E304F

P2093

Q34405506-18977EEE-1D54-4DED-A521-66917FE82F84

Q34405506-321AEE18-281C-42FA-B1D2-406B57317A40

Q34405506-395B0FB9-E0A8-41D8-A362-4E37C0E156CE

Q34405506-45C4F193-805C-411E-AA80-597EE3B33216

Q34405506-86C6B59E-F0CF-48EA-BBD7-334564FD3272

Q34405506-97D23993-72AF-4D60-9BC0-EF0A4E23B37D

Q34405506-B59E22D4-BF17-4266-8223-8C4E0F61328F

Q34405506-E6A45F7C-1B64-45D6-971D-21760B6ED95B

Q34405506-F7699009-6045-4EEE-AE4D-594FB0B03966

P2860

Q34405506-04CA62A1-A8AC-4B98-8F10-737C15322E7C

Q34405506-10C62836-1201-4159-A0A3-2DA5BBA68034

Q34405506-16F900C0-1DFA-45FA-BB53-525E216980E5

Q34405506-1FDC82A8-14E6-4114-8295-6284966C2D77

Q34405506-24AA412A-61C3-4B87-B07A-00C04FBBFB31

Q34405506-26DC018E-10D3-438A-B015-875E16106133

Q34405506-2790D01B-A38F-43A6-ABB9-4001C905D31D

Q34405506-279DF306-F573-4CB4-A066-6C6F1CCC9CE0

Q34405506-2B291227-2976-4EA9-B792-008D05D2F190

Q34405506-3537EB48-5A79-4A6D-9F43-412D6A392C5C

P304

Q34405506-716D21B5-3D28-4ED7-B9AE-AAD41B5C18EB

P31

Q34405506-D4A56EC7-AD9F-4C7E-A62F-06239B262244

P356

Q34405506-3EA58476-54FA-4D71-B497-A5BD1250CFF3

P407

Q34405506-832DFB9F-66DC-4B17-945B-6C332CB0649B

P433

Q34405506-D6227D21-3C70-45CD-9C6C-4966B651D219

P478

Q34405506-1FC6E03B-73F9-4250-B4D4-DFC4372F26CF

P50

Q34405506-4446875E-B254-4F3D-B9BB-71C33C89C095

P577

Q34405506-D42468DA-79F6-41D5-BC46-61398207AE62

P5875

Q34405506-52636A27-F312-475F-BB2A-6A60AA06A196

P698

Q34405506-BB8B482A-127F-48D2-B957-FAD513932B8C

P921

Q34405506-369DB90E-CBE0-4A49-86F1-8566B15786FA

P932

Q34405506-A1AB895A-6AA1-4E0A-9AF5-4D0B90D3B6D9

P356

JOURNAL.PONE.0043726

P1433

P1476

Hypoxia induced aggressiveness ...... As that are attenuated by CDF.

@en

P2093

Aamir Ahmad

http://www.w3.org/2001/XMLSchema#string

Asfar S Azmi

http://www.w3.org/2001/XMLSchema#string

Bin Bao

http://www.w3.org/2001/XMLSchema#string

Dejuan Kong

http://www.w3.org/2001/XMLSchema#string

Fazlul H Sarkar

http://www.w3.org/2001/XMLSchema#string

Sanjeev Banerjee

http://www.w3.org/2001/XMLSchema#string

Shadan Ali

http://www.w3.org/2001/XMLSchema#string

Subhash Padhye

http://www.w3.org/2001/XMLSchema#string

Yiwei Li

http://www.w3.org/2001/XMLSchema#string

P2860

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia

MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

MicroRNA-210: a unique and pleiotropic hypoxamir

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

MiR-210--micromanager of the hypoxia pathway

MicroRNA-210 as a novel therapy for treatment of ischemic heart disease

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

P304

e43726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0043726

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Fazlul H. Sarkar

P577

2012-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230805302

http://www.w3.org/2001/XMLSchema#string

P698

22952749

http://www.w3.org/2001/XMLSchema#string

P921

P932

3428287

http://www.w3.org/2001/XMLSchema#string